Staging and Evaluation of the Patient with Lymphoma

被引:27
作者
Cheson, Bruce D. [1 ]
机构
[1] Georgetown Univ Hosp, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
关键词
Response criteria; Non-Hodgkin's lymphoma; Hodgkin lymphoma; PET Scan;
D O I
10.1016/j.hoc.2008.07.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Patients who have non-Hodgkin's lymphoma or Hodgkin lymphoma most often present for medical attention because of signs or symptoms referable to enlarged lymph nodes or other disease-related symptoms (such as fevers, night sweats or fatigue). Less often, enlarged lymph nodes or splenomegaly may be incidental findings during evaluation for other medical issues. Determination of the extent of disease and accurate assessment of responses are necessary for appropriate management. Newer technologies have improved the ability to evaluate patients and to conduct clinical trials, leading to more effective therapies. This article addresses the advances in staging and evaluation of patients who have lymphoma, specifically examining the use of positron emission tomography.
引用
收藏
页码:825 / +
页数:15
相关论文
共 67 条
[1]   Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDC-PET) for accurate staging of Hodgkin's disease [J].
Bangerter, M ;
Moog, F ;
Buchmann, I ;
Kotzerke, J ;
Griesshammer, M ;
Hafner, M ;
Elsner, K ;
Frickhofen, N ;
Reske, SN ;
Bergmann, L .
ANNALS OF ONCOLOGY, 1998, 9 (10) :1117-1122
[2]   Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma [J].
Blum, RH ;
Seymour, JF ;
Wirth, A ;
MacManus, M ;
Hicks, RJ .
CLINICAL LYMPHOMA, 2003, 4 (01) :43-49
[3]  
Buchmann I, 2001, CANCER, V91, P889
[4]  
CARBONE PP, 1971, CANCER RES, V31, P1860
[5]   Detection of lymphoma in bone marrow by whole-body positron emission tomography [J].
Carr, R ;
Barrington, SF ;
Madan, B ;
O'Doherty, MJ ;
Saunders, CAB ;
van der Walt, J ;
Timothy, AR .
BLOOD, 1998, 91 (09) :3340-3346
[6]   Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma:: prevalence and scan interpretation [J].
Castellucci, P ;
Nanni, C ;
Farsad, M ;
Alinari, L ;
Zinzani, P ;
Stefoni, V ;
Battista, G ;
Valentini, D ;
Pettinato, C ;
Marengo, M ;
Boschi, S ;
Canini, R ;
Baccarani, M ;
Monetti, N ;
Franchi, R ;
Rampin, L ;
Fanti, S ;
Rubello, D .
NUCLEAR MEDICINE COMMUNICATIONS, 2005, 26 (08) :689-694
[7]   HODGKINS-DISEASE, ALCOHOL, AND VENA-CAVAL OBSTRUCTION [J].
CHESON, BD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 239 (01) :23-24
[8]   Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas [J].
Cheson, BD ;
Horning, SJ ;
Coiffier, B ;
Shipp, MA ;
Fisher, RI ;
Connors, JM ;
Lister, TA ;
Vose, J ;
Grillo-López, A ;
Hagenbeek, A ;
Cabanillas, F ;
Klippensten, D ;
Hiddemann, W ;
Castellino, R ;
Harris, NL ;
Armitage, JO ;
Carter, W ;
Hoppe, R ;
Canellos, GP .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1244-1253
[9]   Revised response criteria for malignant lymphoma [J].
Cheson, Bruce D. ;
Pfistner, Beate ;
Juweid, Malik E. ;
Gascoyne, Randy D. ;
Specht, Lena ;
Horning, Sandra J. ;
Coiffier, Bertrand ;
Fisher, Richard I. ;
Hagenbeek, Anton ;
Zucca, Emanuele ;
Rosen, Steven T. ;
Stroobants, Sigrid ;
Lister, T. Andrew ;
Hoppe, Richard T. ;
Dreyling, Martin ;
Tobinai, Kensei ;
Vose, Julie M. ;
Connors, Joseph M. ;
Federico, Massimo ;
Diehl, Volker .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :579-586
[10]   Utility of FDG-PET scanning in lymphoma by WHO classification [J].
Elstrom, R ;
Guan, L ;
Baker, G ;
Nakhoda, K ;
Vergilio, JA ;
Zhuang, H ;
Pitsilos, S ;
Bagg, A ;
Downs, L ;
Mehrotra, A ;
Kim, S ;
Alavi, A ;
Schuster, SJ .
BLOOD, 2003, 101 (10) :3875-3876